# Mesenchymal Stem Cells (MSC) for Ovarian Cancer

> **NCT02530047** · PHASE1 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 5 (actual)

## Conditions studied

- Ovarian Cancer

## Interventions

- **GENETIC:** MSC-INFβ
- **BEHAVIORAL:** Questionnaires

## Key facts

- **NCT ID:** NCT02530047
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-16
- **Primary completion:** 2019-06-13
- **Final completion:** 2019-06-13
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2019-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02530047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02530047, "Mesenchymal Stem Cells (MSC) for Ovarian Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02530047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*